InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
0.720
+0.065 (9.92%)
Jun 26, 2026, 4:00 PM EDT - Market closed
InspireMD Stock Forecast
NSPR's stock price has decreased by -67.86% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for InspireMD stock have an average target of 3.67, with a low estimate of 3.00 and a high estimate of 4.00. The average target predicts an increase of 409.72% from the current stock price of 0.72.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for InspireMD stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $4 | Buy | Reiterates | $4 | +455.56% | Jun 11, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $6 → $4 | Buy | Reiterates | $6 → $4 | +455.56% | May 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $4 → $3 | Buy | Reiterates | $4 → $3 | +316.67% | May 4, 2026 |
Financial Forecast
Revenue This Year
10.38M
from 8.98M
Increased by 15.55%
Revenue Next Year
21.92M
from 10.38M
Increased by 111.23%
EPS This Year
-0.74
from -0.76
EPS Next Year
-0.61
from -0.74
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.5M | 30.4M | |
| Avg | 10.4M | 21.9M | |
| Low | 8.7M | 17.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.1% | 193.0% | |
| Avg | 15.5% | 111.2% | |
| Low | -3.1% | 66.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.74 | -0.61 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.